Olumiant (Baricitinib): A Newly Approved Janus Kinase Inhibitor for the Treatment of Alopecia Areata

January 2022 in “ PubMed ”

Aditya K. Gupta, Tong Wang, Kimberly Vincent, William Abramovits

Baricitinib Janus Kinase inhibitor Alopecia Areata hair loss Olumiant

TLDR Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

The document discusses the results of two Phase 3 trials of Baricitinib, a Janus Kinase inhibitor, for the treatment of Alopecia Areata. The trials involved a significant number of participants, although the exact number is not specified in the document. The results showed that Baricitinib was effective in treating Alopecia Areata, a condition characterized by hair loss. The drug, marketed as Olumiant®, was subsequently approved for this use. The study was conducted by a team of researchers, including King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, Hordinsky M, Dutronc Y, Wu WS, McCollam J, Chiasserini C, Yu G, Stanley S, Holzwarth K, DeLozier AM, Sinclair R, and the BRAVE-AA Investigators.

View this study on pubmed.ncbi.nlm.nih.gov →

Discuss this study in the Community →

7 / 7 results

research Acne Exacerbation After Tofacitinib Treatment for Alopecia Areata

5 citations , January 2022 in “Dermatology Reports”

Tofacitinib treatment for hair loss may worsen acne.

research Acne Exacerbation After Tofacitinib Treatment for Alopecia Areata

October 2021 in “Dermatology Reports”

Tofacitinib, a hair regrowth treatment, may worsen acne.

research Oral Janus Kinase Inhibitors for the Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis

January 2019 in “프로그램북(구 초록집)”

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

research Balance of Tofacitinib Efficacy and Disease Flare in the Treatment of Alopecia Universalis: A Case Report and Review of the Literature

9 citations , August 2018 in “JAAD Case Reports”

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

research Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib

4 citations , July 2018 in “PubMed”

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

research Tofacitinib 2% Ointment, a Topical Janus Kinase Inhibitor, for the Treatment of Alopecia Areata: A Pilot Study of 10 Patients

48 citations , February 2018 in “Journal of the American Academy of Dermatology”

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

research Tofacitinib for the Treatment of Alopecia Areata and Variants in Adolescents

139 citations , January 2017 in “Journal of the American Academy of Dermatology”

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.